ICON Launches New Functional Service Provision (FSP) Strategy

FSP and resourcing services consolidated into a single division, DOCS

Dublin, Ireland, 6 November, 2012 – ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a new functional resourcing strategy delivered by a dedicated division, DOCS.

DOCS has been a leading provider of resourcing services to the global biopharmaceutical and medical device industry for over 15 years. To meet the growing demand for FSP solutions, DOCS has developed the FSP Delivery Platform™. This combines DOCS' global resourcing engine with the processes, quality oversight, systems, and training and governance structures to drive productivity through flexible FSP models. The DOCS FSP Delivery Platform™ also leverages ICON's extensive therapeutic, geographic and functional expertise to ensure greater efficiencies across customer programs.

"Functional resourcing and FSP continue to grow in popularity as sponsors look for innovative outsourcing strategies that enable them to gain efficiencies and accelerate the development of their pipelines," commented Colin Stanley, President, DOCS. "DOCS' core competency is providing highly talented teams with skills and experience that are aligned with the needs of our clients and which seamlessly integrate with their business. Our new FSP Delivery Platform™ builds on this competency and also allows clients to benefit from the breadth and depth of capabilities and expertise from the wider ICON organisation."

The DOCS FSP business will be led by Barry Balfe, Vice President Global Program Management. Barry has 12 years of clinical research experience and has held leadership positions in both operations and business development for DOCS.

About DOCS
DOCS, a division of ICON plc, is a leading provider of global resourcing solutions to the pharmaceutical, biotechnology and medical device industries. The company specialises in four core service areas: Functional Service Provision, Contract Placement, Permanent Placement and Executive Search. DOCS has a global resourcing network and operational infrastructure across 82 locations in 40 countries enabling access to an extensive global pool of candidates. Further information is available at www.docsglobal.com

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

WCG is continuing its buyout run after acquiring clinical trial solutions firm Trifecta Clinical.

London-based uMed has raised nearly $4.8 million from U.K. and U.S. VCs to help healthcare providers participate in more clinical studies.

Amgen has teamed up with cloud-based trial solutions firm Reify Health to help boost patients into its drug studies.